Precision BioSciences - DTIL Net earnings per share for the last four quarters
This daily price chart for Precision BioSciences (DTIL) reflects a trend where the current indicator stands at 85.30. Precision BioSciences is implementing environmental filters and green energy to comply with ESG standards. The business relies on the ARCUS AI system, which automates genome editing and eliminates routine laboratory tasks. Growth potential is driven by massive demand for licenses from pharmaceutical behemoths.
Precision BioSciences, Inc. - analytical breakdowns and key metrics (DTIL)
- market price and analyst price targets:
- issuer market value details:
- book value of equity indicators:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Precision BioSciences|DTIL - Long-Term Debt to Capital|Short-Term Debt to Equity Precision BioSciences Inc.|DTIL - Company Aggregate Debts|Debts to Net Assets Precision BioSciences Inc.|DTIL - Company Long-Term Debt|Short-Term Debt Precision BioSciences|Interim Coverage Ratio precisionbiosciences.com
- net income and valuation ratios data:
DTIL - Net Profit|Future Profit Precision BioSciences|DTIL - P/E Multiple|Market Cap to Projected Earnings precisionbiosciences.com|DTIL - PEG Multiple|Company Value to EBITDA Precision BioSciences Inc.|DTIL - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Precision BioSciences|DTIL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months precisionbiosciences.com|DTIL - Earnings growth in current year|Expected net earnings per share growth next year Precision BioSciences
Fundamental company valuation:DTIL (precisionbiosciences.com)
Licensing payment flows from pharma behemoths for the use of ARCUS technology determine the financial stability of Precision BioSciences (DTIL). Analyzing this chart of relative EPS YoY TTM changes, an investor can observe the earnings per share trend over a rolling year, which allows for the exclusion of one-time accounting adjustments and an assessment of the real efficiency of business scaling through the prism of long-term net income growth.
Competitor analysis
Net earnings per share for the last four quarters Tempus AI, Inc. TEM|QGEN: Net earnings per share (EPS TTM)|IONS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Repligen Corp.|Net earnings per one share for the last twelve months Avidity Corp RNA|Earnings per share for the last twelve months CRISPR Therapeutics AG (CRSP)|genedx.com - Earnings per share for the last 12 months|Ultragenyx - Net earnings per share for the last 12 months|Earnings per share for the trailing year BEAM|Sarepta Therapeutics Inc - Net earnings per share (EPS TTM)|TWST: Earnings per share for the last twelve months|TXG: Net earnings per share (EPS TTM)|NTLA - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Stoke Therapeutics, Inc.|Net earnings per one share for the last twelve months BioLife Solutions Inc BLFS|Earnings per share for the last twelve months Wave Life Sciences Corp (WVE)|Net earnings per share for the last four quarters Maze Therapeutics Corp|Net earnings per share (EPS TTM) SION (Sionna Therapeutics Inc)|PRME - Net earnings per share for the last 12 months|Taysha Gene Therapies, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters uniQure NV QURE|MGTX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months REGENXBIO Corp (RGNX)|Earnings per share for the last twelve months Solid Biosciences Inc.|Earnings per share for the last 12 months OCGN (ocugen.com)|Net earnings per share (EPS TTM) PACB|Net earnings per share for the last 12 months Benitec Biopharma Inc BNTC|Net earnings per share (EPS TTM) DSGN (Design Pharma)|Rocket Corp (RCKT) - Net earnings per one share for the last twelve months|FDMT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Lexeo Therapeutics LXEO|KRRO: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months EDIT|Net earnings per share for the last 12 months SLN|PRQR (ProQR Therapeutics NV) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) CDXS|Net earnings per share for the last four quarters sangamo.com|Earnings per share for the last twelve months Nautilus Bio NAUT|Metagenomi Inc. - Earnings per share for the last twelve months|Generation Bio Corp - Net earnings per share (EPS TTM)|BOLD (Boundless Bio Inc) - Earnings per share for the last 12 months|exicuretx.com (XCUR) - Earnings per share for the last twelve months|Earnings per share for the last 12 months IMNN|PHIO (Phio Pharmaceuticals Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Mustang Bio Corp|Earnings per share for the last twelve months TransCode Therapeutics (RNAZ)|BNGO: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Applied DNA Sciences APDN|Earnings per share for the trailing year BLUE|ImmunoPrecise - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Omega Therapeutics Inc|OMIC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Regulus|SYRS (Syros Pharmaceuticals) - Net earnings per share (EPS TTM)|telesisbio.com (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months TRACON Pharmaceuticals, Inc. (TCON)|Net earnings per share for the last four quarters Unity Biotechnology Inc.
